Indication
Mesothelin-positive Advanced Refractory Solid Tumors
1 clinical trial
1 product
2 drugs
Clinical trial
Safety and Efficacy Study of Novel Mesothelin CAR-T Cell Therapy in Patients With Mesothelin-positive Advanced Refractory Solid TumorsStatus: Withdrawn, Estimated PCD: 2025-04-30
Product
Anti-mesothelin CAR-T cellsDrug
fludarabineDrug
cyclophosphamide